Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells Retraction in /10.3892/mmr.2024.13258

Liao,Yi‑Xiang; Zeng,Jin‑Min; Zhou,Jia‑Jie; Yang,Guang‑Hua; Ding,Kun; Zhang,Xian‑Jue

doi:10.3892/mmr.2016.5127

Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells

Retraction in: /10.3892/mmr.2024.13258

Authors:
- Yi‑Xiang Liao
- Jin‑Min Zeng
- Jia‑Jie Zhou
- Guang‑Hua Yang
- Kun Ding
- Xian‑Jue Zhang
View Affiliations

Affiliations: Department of Urology, Jingzhou Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jingzhou, Hubei 434020, P.R. China
Published online on: April 14, 2016 https://doi.org/10.3892/mmr.2016.5127
Pages: 4872-4878

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human bladder cancer is the most common urological malignancy in China. One of the causes of carcinogenesis in the cancer may be gene mutation. Therefore, the present study investigated the expression levels of Rhotekin 2 (RTKN2), a Rho effector protein, in human bladder cancer tissues and cell lines, and examined the effect of RTKN2 on the proliferation, cell cycle, apoptosis and invasion of human bladder cancer cell lines. The mRNA expression levels of RTKN2 in 30 human bladder cancer tissue samples were significantly higher, compared with those in 30 normal human bladder tissue samples. The protein expression levels of RTKN2 was markedly higher in T24 and 5637 cells, compared with those in four other human bladder cancer cell lines. The silencing of RTKN2 by small interfering (si)RNA inhibited cell proliferation and arrested cell cycle at the G1 phase, via reducing the expression levels of the MCM10, CDK2, CDC24A and CDC6 cell cycle‑associated proteins in the T24 and 5637 cells. Furthermore, RTKN2 knockdown in the cells led to cell apoptosis and the suppression of invasion. These results suggested that RTKN2 is involved in the carcinogenesis and progression of human bladder cancer, indicating that RTKN2 may be a molecular target in cancer therapy.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Hirata T, Watanabe M, Kaku H, Kobayashi Y, Yamada H, Sakaguchi M, Takei K, Huh NH, Nasu Y and Kumon H: REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer. Int J Oncol. 41:559–564. 2012.PubMed/NCBI
3	Collier FM, Baker AJ, Walder K, Stupka N, Martin SD and Kirkland MA: A Rho-GTPase effector, Rhotekin-2 (RTKN2) is associated with BMP8b and IL-16 cytokine expression and increased sensitivity to apoptosis in lymphocytes. Blood. 110:22932007.
4	Collier FM, Gregorio-King CC, Gough TJ, Talbot CD, Walder K and Kirkland MA: Identification and characterization of a lymphocytic Rho-GTPase effector: Rhotekin-2. Biochem Biophys Res Commun. 324:1360–1369. 2004. View Article : Google Scholar : PubMed/NCBI
5	Collier FM, Loving A, Baker AJ, McLeod J, Walder K and Kirkland MA: RTKN2 induces NF-KappaB dependent resistance to intrinsic apoptosis in HEK cells and regulates BCL-2 genes in human CD4(+) lymphocytes. J Cell Death. 2:9–23. 2009.PubMed/NCBI
6	Dat le T, Matsuo T, Yoshimaru T, Kakiuchi S, Goto H, Hanibuchi M, Kuramoto T, Nishioka Y, Sone S and Katagiri T: Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice. Int J Oncol. 40:1455–1469. 2012.PubMed/NCBI
7	Gregorio-King CC, Gough T, Van Der Meer GJ, Hosking JB, Waugh CM, McLeod JL, Collier FM and Kirkland MA: Mechanisms of resistance to the cytotoxic effects of oxysterols in human leukemic cells. J Steroid Biochem Mol Biol. 88:311–320. 2004. View Article : Google Scholar : PubMed/NCBI
8	Aupeix K, Weltin D, Mejia JE, Christ M, Marchal J, Freyssinet JM and Bischoff P: Oxysterol-induced apoptosis in human monocytic cell lines. Immunobiology. 194:415–428. 1995. View Article : Google Scholar : PubMed/NCBI
9	Ayala-Torres S, Moller PC, Johnson BH and Thompson EB: Characteristics of 25-hydroxycholesterol-induced apoptosis in the human leukemic cell line CEM. Exp Cell Res. 235:35–47. 1997. View Article : Google Scholar : PubMed/NCBI
10	Gregorio-King CC, Collier FM, Bolton KA, Ferguson M, Hosking JB, Collier GR and Kirkland MA: Effect of oxysterols on hematopoietic progenitor cells. Exp Hematol. 30:670–678. 2002. View Article : Google Scholar : PubMed/NCBI
11	Shephard DA: The 1975 Declaration of Helsinki and consent. Can Med Assoc J. 115:1191–1192. 1976.PubMed/NCBI
12	Payton JE, Grieselhuber NR, Chang LW, Murakami M, Geiss GK, Link DC, Nagarajan R, Watson MA and Ley TJ: High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest. 119:1714–1726. 2009. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
14	Yin TY, Hsiao YW, Peng WH, Wang MJ and Chen JY: Overexpression of Rhotekin confers gastric cancer cells resistance to interferon-{alpha}-mediated growth inhibition. Cancer Res. 72:44352012. View Article : Google Scholar
15	Myouzen K, Kochi Y, Okada Y, Terao C, Suzuki A, Ikari K, Tsunoda T, Takahashi A, Kubo M, Taniguchi A, et al: Functional variants in NFKBIE and RTKN2 involved in activation of the NF-κB pathway are associated with rheumatoid arthritis in Japanese. PLoS Genet. 8:e10029492012. View Article : Google Scholar
16	Li W, Wu YF, Xu RH, Lu H, Hu C and Qian H: miR-1246 releases RTKN2-dependent resistance to UVB-induced apoptosis in HaCaT cells. Mol Cell Biochem. 394:299–306. 2014. View Article : Google Scholar : PubMed/NCBI
17	Gregorio-King C, Gough T, Collier F and Kirkland M: RTKN2-A novel gene differentially expressed in CD34+ cells from umbilical cord blood, normal and AML bone marrow. Exp Hematol. 31:206–207. 2003.
18	Wang S, Bian C, Yang Z, Bo Y, Li J, Zeng L, Zhou H and Zhao RC: miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol. 34:1461–1466. 2009.PubMed/NCBI
19	Sevli S, Uzumcu A, Solak M, Ittmann M and Ozen M: The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis. 13:208–217. 2010. View Article : Google Scholar : PubMed/NCBI
20	Malumbres M and Barbacid M: Mammalian cyclin-dependent kinases. Trends Biochem Sci. 30:630–641. 2005. View Article : Google Scholar : PubMed/NCBI
21	Massagué J: G1 cell-cycle control and cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
22	van den Heuvel S and Harlow E: Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:2050–2054. 1993. View Article : Google Scholar : PubMed/NCBI
23	Tetsu O and McCormick F: Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell. 3:233–245. 2003. View Article : Google Scholar : PubMed/NCBI
24	Piatti S, Lengauer C and Nasmyth K: Cdc6 is an unstable protein whose de novo synthesis in G1 is important for the onset of S phase and for preventing a 'reductional' anaphase in the budding yeast Saccharomyces cerevisiae. EMBO J. 14:3788–3799. 1995.PubMed/NCBI
25	Zwerschke W, Rottjakob HW and Küntzel H: The Saccharomyces cerevisiae CDC6 gene is transcribed at late mitosis and encodes a ATP/GTPase controlling S phase initiation. J Biol Chem. 269:23351–23356. 1994.PubMed/NCBI
26	Feng D, Tu Z, Wu W and Liang C: Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res. 63:7356–7364. 2003.PubMed/NCBI
27	Lau E, Zhu C, Abraham RT and Jiang W: The functional role of Cdc6 in S-G2/M in mammalian cells. EMBO Rep. 7:425–430. 2006.PubMed/NCBI
28	Perona R, Moncho-Amor V, Machado-Pinilla R, Belda-Iniesta C and Sánchez Pérez I: Role of CHK2 in cancer development. Clin Transl Oncol. 10:538–542. 2008. View Article : Google Scholar : PubMed/NCBI
29	Merchant AM, Kawasaki Y, Chen Y, Lei M and Tye BK: A lesion in the DNA replication initiation factor Mcm10 induces pausing of elongation forks through chromosomal replication origins in Saccharomyces cerevisiae. Mol Cell Biol. 17:3261–3271. 1997. View Article : Google Scholar : PubMed/NCBI
30	Izumi M, Yatagai F and Hanaoka F: Cell cycle-dependent proteolysis and phosphorylation of human Mcm10. J Biol Chem. 276:48526–48531. 2001.PubMed/NCBI
31	Hong Y and Stambrook PJ: Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA. 101:14443–14448. 2004. View Article : Google Scholar : PubMed/NCBI